Colorectal cancer screening tests are carried to monitor bowel health of at-risk individuals, typically the elderly, in order to be able to detect and treat colorectal cancer in a timely manner.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Colorectal Cancer Screening Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acuamark Diagnostics Inc
- Advanced Marker Discovery SL
- Anixa Diagnostics Corporation
- Arbele Corp
- Augusta University
- Bar Harbor BioTechnology Inc (Inactive)
- Beacon Biomedical Inc
- Beckman Research Institute Of The City Of Hope
- Beijing Youxun Medical Laboratory Co Ltd
- BGI Genomics Co Ltd
- Biocept Inc
- Biome Diagnostics GmbH
- Castle Biosciences Inc
- CellMax Life Inc
- Celtic Medical BV
- CRC Bioscreen
- Creative Biosciences (Guangzhou) Co Ltd
- Curo Biosciences Pvt Ltd
- Diagen
- DiagNodus Ltd
- EHang (Suzhou) Biomedical Co Ltd
- Epigenomics Inc
- Exact Sciences Corp
- Faknostics LLC
- Foundation Medicine Inc
- G Medical Health and Wellness
- Geneoscopy LLC
- Genetic Technologies Ltd
- Genetron Health (Beijing) Co Ltd
- Genoptix Inc (Inactive)
- Guardant Health Inc
- Hangzhou Heyi Gene Technology Co Ltd
- Human Metabolome Technologies Inc
- iCellate Medical AB
- Interpace Biosciences Inc
- JL Medi Labs Co Ltd
- Mainz Biomed NV
- mBioSys Pvt Ltd
- Neuome Peptides Pte Ltd
- New Day Diagnostics LLC
- Nucleix Ltd
- Ohio State University
- Oncodiag
- Oncomark Ltd
- Ourotech Ltd
- Prenetics Ltd
- Preora Healthcare Inc
- QuantuMDx Group Ltd
- Rarity Bioscience AB
- Rhythm Biosciences Ltd
- Shanghai Singlera Genomics Technologies Co Ltd
- Shenzhen Youshengkang Biotechnology Co., Ltd.
- Singlera Genomics Inc
- Surfix BV
- The Chinese University of Hong Kong
- Thermo Fisher Scientific Inc
- University of Helsinki
- University of Oxford
- Vastcon Inc
- VolitionRX Ltd
- Zhongjing Pukang (Beijing) Pharmaceutical Technology Co., Ltd

